These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 12053072

  • 1. Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.
    Catalano C, Gianesini C, Fabbian F.
    Nephron; 2002 Jun; 91(2):324-6. PubMed ID: 12053072
    [Abstract] [Full Text] [Related]

  • 2. Mitomycin-C induced hemolytic uremic syndrome: a case report.
    Gundappa RK, Sud K, Kohli HS, Gupta KL, Joshi K, Sakhuja V.
    Ren Fail; 2002 May; 24(3):373-7. PubMed ID: 12166705
    [Abstract] [Full Text] [Related]

  • 3. Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
    Shah R, Beem E, Sautina L, Zharikov SI, Segal MS.
    Nephrol Dial Transplant; 2007 Feb; 22(2):617-20. PubMed ID: 17041000
    [No Abstract] [Full Text] [Related]

  • 4. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
    Schiebe ME, Hoffmann W, Belka C, Bamberg M.
    Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F.
    Dtsch Med Wochenschr; 2004 Jul 02; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract] [Full Text] [Related]

  • 7. Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy.
    Groff JA, Kozak M, Boehmer JP, Demko TM, Diamond JR.
    Am J Kidney Dis; 1997 Feb 02; 29(2):280-4. PubMed ID: 9016902
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE, Phillips TM, Schein PS.
    J Clin Oncol; 1985 May 02; 3(5):723-34. PubMed ID: 3923162
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Three cases of drug-induced hemolytic uremic syndrome].
    Tohda S, Shiigai T, Jibiki M, Aoi T, Ueda Y, Kawasaki T, Kurokawa H, Nara N.
    Gan To Kagaku Ryoho; 1996 Feb 02; 23(3):361-4. PubMed ID: 8712831
    [Abstract] [Full Text] [Related]

  • 14. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
    Arola O, Aho H, Asola M, Kauppila M, Nikkanen V, Voipio-Pulkki LM.
    Duodecim; 1997 Feb 02; 113(19):1923-9. PubMed ID: 10892085
    [No Abstract] [Full Text] [Related]

  • 15. [Mitomycin-induced hemolytic-uremic syndrome].
    Zeller G, Wandel E, Schwarting A.
    Dtsch Med Wochenschr; 2003 Jun 20; 128(25-26):1399-402. PubMed ID: 12813674
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome.
    Borghardt EJ, Kirchertz EJ, Marten I, Fenchel K.
    Transfus Sci; 1998 Mar 20; 19 Suppl():5-7. PubMed ID: 10178695
    [Abstract] [Full Text] [Related]

  • 18. Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report.
    Verwey J, Boven E, van der Meulen J, Pinedo HM.
    Cancer; 1984 Dec 15; 54(12):2878-81. PubMed ID: 6437662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.